Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jilg

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Journal of Hepatology|April 1, 1988
Persistence of specific antibodies after hepatitis B vaccinationW Jilg, M Schmidt, F Deinhardt
Zeitschrift Fur Gastroenterologie|August 18, 2004
[Immune prophylaxis of hepatitis B]W Jilg, C Rink, B Kallinowski
La Ricerca in Clinica E in Laboratorio|January 1, 1988
[Viral hepatitis in the newborn infant]E Deinhardt, C Rosendahl, W Jilg
Deutsche Medizinische Wochenschrift (1946)|August 19, 1983
[Immunoprophylaxis of hepatitis B. 3. Results of clinical studies with hepatitis B vaccines]G Zoulek, W Jilg, F Deinhardt
Scandinavian Journal of Infectious Diseases|January 1, 1994
Substantial decline of notified hepatitis B in major parts of Europe after 1985S Iwarson, W Jilg, T Stroffolini
Deutsche Medizinische Wochenschrift (1946)|November 25, 1994
[The clinical importance of the polymerase chain reaction in infectious disease diagnosis]J Mayer, U Reischl, W Jilg
Lancet (London, England)|January 20, 1990
Decline of anti-HBs after hepatitis B vaccination and timing of revaccinationW Jilg, M Schmidt, F Deinhardt
Thrombosis Research|November 1, 1976
Isolation of residual fibrinogen from a supernatant of plasma precipitated with 2.1 M glycineW Jilg, H Priess, H Hörmann
Deutsche Medizinische Wochenschrift (1946)|August 5, 1983
[Immunoprophylaxis of hepatitis B. 2. Active immunization: vaccine production, vaccine safety, side effects]G Zoulek, W Jilg, F Deinhardt
Versicherungsmedizin|April 1, 1991
[Possible long-term prognosis in epidemiologically significant virus infections]L Gürtler, W Jilg, H K Kraus
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Journal of Hepatology|April 1, 1988
Persistence of specific antibodies after hepatitis B vaccinationW Jilg, M Schmidt, F Deinhardt
Zeitschrift Fur Gastroenterologie|August 18, 2004
[Immune prophylaxis of hepatitis B]W Jilg, C Rink, B Kallinowski
La Ricerca in Clinica E in Laboratorio|January 1, 1988
[Viral hepatitis in the newborn infant]E Deinhardt, C Rosendahl, W Jilg
Deutsche Medizinische Wochenschrift (1946)|August 19, 1983
[Immunoprophylaxis of hepatitis B. 3. Results of clinical studies with hepatitis B vaccines]G Zoulek, W Jilg, F Deinhardt
Scandinavian Journal of Infectious Diseases|January 1, 1994
Substantial decline of notified hepatitis B in major parts of Europe after 1985S Iwarson, W Jilg, T Stroffolini
Deutsche Medizinische Wochenschrift (1946)|November 25, 1994
[The clinical importance of the polymerase chain reaction in infectious disease diagnosis]J Mayer, U Reischl, W Jilg
Lancet (London, England)|January 20, 1990
Decline of anti-HBs after hepatitis B vaccination and timing of revaccinationW Jilg, M Schmidt, F Deinhardt
Thrombosis Research|November 1, 1976
Isolation of residual fibrinogen from a supernatant of plasma precipitated with 2.1 M glycineW Jilg, H Priess, H Hörmann
Deutsche Medizinische Wochenschrift (1946)|August 5, 1983
[Immunoprophylaxis of hepatitis B. 2. Active immunization: vaccine production, vaccine safety, side effects]G Zoulek, W Jilg, F Deinhardt
Versicherungsmedizin|April 1, 1991
[Possible long-term prognosis in epidemiologically significant virus infections]L Gürtler, W Jilg, H K Kraus
Pageof 15